Written on behalf the International Research Network on COVID-19 Impact on Cancer Care.

ACKNOWLEDGMENT
We thank all the participants and sites who participated as part of the International Research Network on COVID-19 Impact on Cancer Care (see the Data Supplement for a list of all contributors and their affiliations).

AUTHOR CONTRIBUTIONS
Conception and design: Abdul Rahman Jazieh, Hakan Akbulut, Giuseppe Curigliano, Alvaro Rogado, Abdullah Ali Alsharm, Layth Mula-Hussain, Hassan Errihani, Adnan Khattak, Mohammad Omar Farouq Alkaiyat, Christian Rolfo
Provision of study material or patients: All authors
Collection and assembly of data: Mohammad Omar Farouq Alkaiyat, Hoda Jradi
Data analysis and interpretation: Abdul Rahman Jazieh, Hakan Akbulut, Giuseppe Curigliano, Alvaro Rogado, Abdullah Ali Alsharm, Evangelia D. Razis, Layth Mula-Hussain, Hassan Errihani, Adnan Khattak, Clarissa Mathias, Mohammad Omar Farouq Alkaiyat, Hoda Jradi, Christian Rolfo
Manuscript writing: All authors
Final approval of manuscript: All authors
Accountable for all aspects of the work: All authors

AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/go/site/misc/authors.html.
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).

Abdul Rahman Jazieh
Research Funding: MSD Oncology
Travel, Accommodations, Expenses: AstraZeneca, Bristol Myers Squibb

Giuseppe Curigliano
Honoraria: Ellipses Pharma
Consulting or Advisory Role: Roche, Genentech, Pfizer, Novartis, Eli Lilly, Foundation Medicine, Bristol Myers Squibb, Samsung, AstraZeneca, Daiichi Sankyo, Boehringer Ingelheim, GlaxoSmithKline, Seattle Genetics
Speakers’ Bureau: Roche, Genentech, Novartis, Pfizer, Eli Lilly, Foundation Medicine, Samsung, Daiichi Sankyo
Research Funding: Merck (Inst)
Travel, Accommodations, Expenses: Roche, Genentech, Pfizer

Evangelia D. Razis
Consulting or Advisory Role: AstraZeneca, Bristol Myers Squibb, Pfizer
Research Funding: Novartis, Demo Pharmaceutical, Celldex, PAREXEL, Tesaro, Anabiosis Pharmaceuticals, Radius Health
Travel, Accommodations, Expenses: Genesis Pharmaceuticals, LEO Pharma, Roche, Genekor, Merck, Ipsen, Sanofi

Hassan Errihani
Consulting or Advisory Role: Pfizer, Roche, MSD, Merck
Speakers’ Bureau: Novartis, Amgen
Research Funding: Roche
Travel, Accommodations, Expenses: Pierre Fabre (Inst), Merck (Inst)

Roselle B. De Guzman
Honoraria: Roche Oncology (Philippines), AstraZeneca, Novartis, Merck Serono, MSD Oncology, Boehringer Ingelheim
Consulting or Advisory Role: Roche, Novartis, Boehringer Ingelheim, AstraZeneca, Centus Biotherapeutics
Travel, Accommodations, Expenses: Hospira (Philippines), Roche (Philippines), Merck Sharp & Dohme, Eisai, Boehringer Ingelheim, AstraZeneca, Eli Lilly, Novartis

Christian Rolfo
Consulting or Advisory Role: Mylan, Archer Biosciences, Oncompass, Inivata, Merck Serono
Speakers’ Bureau: Novartis, MSD, Boehringer Ingelheim, Guardant Health, AstraZeneca
Research Funding: Lung Cancer Research Foundation, Pfizer
Travel, Accommodations, Expenses: AstraZeneca
Uncompensated Relationships: OncoDNA, Biomark, Guardant Health,
No other potential conflicts of interest were reported.